RxDoctor Payments Data

W B Younger

Hematology & Oncology · Boston, MANPI 1285615112

Payments from drug & device makers

$145,455in general payments, 2019–2025

Across 42 payments — averaging $3463.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$91K
  • Astrazeneca UK Limited$34K
  • Acerta Pharma LLC$18K
  • Beigene, Ltd.$3K
$220,510in research payments, 2019–2025

Across 82 payments — averaging $2689.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pharmacyclics LLC, An Abbvie Company$76K
  • AbbVie$65K
  • Dr.reddy's Laboratories,inc.$48K
  • Beone Medicines Ltd.$15K
  • Beigene, Ltd.$15K
  • Novartis Pharma AG$210

What the payments were for

  • Consulting fees$145,455100%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck23$91,195
Astrazeneca UK Limited8$33,830
Acerta Pharma LLC5$17,655
Beigene, Ltd.6$2,775

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$145,455 in reported general payments places this provider in the 65th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Other hematology & oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →